From CEO’s Desk
It is always an exciting time as we progress into the third quarter of each year because it is during this phase that we can see most of our efforts blossom into something of significance. At this juncture also, I would like to take this opportunity to highlight the fantastic achievements of our doctors in driving more high-quality clinical trials here in Malaysia. In recognising their contributions, we have held our annual Clinical Trials Day where we awarded them with the CRM Industry Sponsored Research Award – an award given to high achievers in clinical trials in Malaysia. We hope that with such awards, more people will step up their game in their respective fields.
As CRM is growing at a rapid pace, we recognise the importance of forging partnerships with global entities that are paving the way for better healthcare. To begin with, we have the National University Hospital Singapore (NUHS) team visiting the Director-General of Health, Datuk Dr. Noor Hisham in Malaysia. NUHS has also shown a strong interest to collaborate with Malaysia in clinical research and training. With this, we have reached another important milestone in our Phase 1 Realization Project. Next – with amazing help from our South Korean counterpart, C&R Research Inc. – the CRM team together with Datuk Dr. Noor Hisham went for a series of business networking meetings in Seoul. During the visit, we took the opportunity to promote Malaysia’s clinical research capabilities to the pharmaceutical companies in Korea in a bid to encourage them to conduct clinical trials here in Malaysia. I truly believe that by building trust with our current partners and expanding trust to our future partners, we will be able to position Malaysia as the site for sponsored research in this region.
As our faithful readers might know, one of our aims at CRM is to become a truly global research organisation. In line with our core values of Transparency, Honesty, Accountability & Trustworthiness, we strive to achieve the highest standards in the way we conduct our business. As such, we are currently at the final phases of obtaining the ISO 9001:2015 accreditation, which we work very hard to obtain since last year. Being accredited with ISO 9001: 2015 will demonstrate the quality of management we are practicing within CRM and the consistent standard quality of clinical trials that are being conducted at all sites in Malaysia. We hope to achieve and obtain this accreditation by early 2019.
Finally, I would like to also take this opportunity to thank all of our people in CRM for striving hard in making the organisation a strong force it is today. For our readers, I hope you will enjoy reading this bulletin and will gain more insight on what we do, the kind of activities we conduct and most importantly, appreciate the efforts the whole community is putting in to make our world a better place to live in.
Dr. Akhmal Yusof
CEO, Clinical Research Malaysia
Heartiest Congratulations to Dato’ Dr Goh Pik Pin (National Clinical Research Centre Director) on being conferred the Darjah Setia Pangkuan Negeri (D.S.P.N), carrying the title Dato’, by Yang di-Pertua Negeri Pulau Pinang, His Excellency Tun Dato’ Seri Utama (Dr.) Haji Abdul Rahman bin Haji Abbas on July 17, 2018.
From the Management & Staff of Clinical Research Malaysia (CRM).
List of Clinical Trial Sites who achieved a significant milestone globally! Clinical Research Malaysia would like to congratulate to all the study team below:
Kedah won the Dato’ Esah’s Trophy for The Best State in Research recently at the 10th National Pharmacy R&D Conference 2018 organised by Pharmaceutical Services Programme, Ministry of Health Malaysia and Malaysian Pharmaceutical Society held at the Royale Chulan Hotel, Seremban between 9-11 July 2018.
Clinical Research Malaysia (CRM) would like to take this opportunity to congratulate all winners!
Semiconductors in Life Sciences Symposium Penang, 18th September 2018
Hosted by SilTerra Malaysia, Supported by imec
The convergence of micro-electronics and life sciences is poised to take the next leap of advancement.
Ever since the retail introduction of glucometers and glucose strips, the lives of millions of diabetic sufferers changed dramatically. This was enabled because an accurate electrical signal could be generated from blood sugar by the presence of glucose oxidase in the strip. Other point-of-care applications have since emerged and expanded beyond this approach.
The recognition that micro-electronics and semiconductor processing can revolutionize healthcare has led renowned research institutes around the world like imec with headquarters in Belgium, Europe to pursue this field. SilTerra has been collaborating with imec to commercialise the next generation micro-chip applications like photonics-based DNA sequencing chips, semiconductor-based ultrasonics transducers, micro-fluidics based lab-on-a-chip systems and others.
SilTerra, supported by imec, is organising a technology symposium that will bring together thought leaders and eminent researchers to share and collaborate in accelerating this field of semiconductors in life sciences. We invite technologists and thought leaders from:
Research Institutes working on semiconductor-based life sciences applications that are on the verge of commercialisation, and
Companies who have techniques and methods for supporting these technologies to
Submit presentation proposals1 for sharing with other eminent persons at this event.
We have invited speakers from Europe, Asia and USA to share the latest in their respective areas – in addition to imec, we expect to include companies such as Pacific Biosciences, MEMS Journal, AmKor Technology, Korea Electronics Technology Institute, and others.
The audience will be technologists and senior technology managers from leading companies and research institutes who are also extending the boundaries of life sciences through semiconductor and related technologies – from Europe, Asia and USA.
This will be an invitation-only one-day symposium limited to no more than 100 attendees and a maximum of 10 talks. There will be ample opportunity for networking to encourage collaboration during the day.
Details of the event will be available soon. The deadline for submission is 23rd July. Join us as a speaker.
DATE OF EVENT: 18th September 2018
VENUE: UAB Building, Gat Lebuh Cina, Penang The event will be held in the beautifully restored heritage UAB Building, location of Khazanah’s Penang Office in Georgetown.
DEADLINE FOR ABSTRACT SUBMISSION: July 23rd 2018. Accepted abstracts will be notified by 8th August to prepare presentations not exceeding 18 min, in the style of TED Talks.
SUBMISSIONS & QUERIES: Susan Sahayan ( email@example.com )
SilTerra Malaysia Sdn Bhd is a semiconductor wafer foundry offering fabrication and design support services in CMOS logic, High-Voltage, Mixed-signal, RF, BCD, Power and MEMS technologies down to 90 nanometer feature size. SilTerra’s wafer fab has a design-in capacity of 46,000 eight-inch wafers per month and currently serves customers in US, Taiwan, Korea and China.
Environmentally vigilant, SilTerra delivers award-winning, world-class performance to its customers seeking flexible capacity, custom technologies, competitive advantages and around the clock customer support. SilTerra is ISO 9001:2008 and ISO 14001 certified. Starting commercial production in 2001, the company’s headquarters and factory are located in Malaysia’s Kulim Hi-Tech Park, with sales and marketing offices in San Jose (California) and Hsinchu (Taiwan). For additional information on SilTerra or its services, please visit www.silterra.com
Supporting partner imec
Imec is the world-leading research and innovation hub in nanoelectronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, energy and education.
As a trusted partner for companies, start-ups and universities we bring together close to 4,000 brilliant minds from over 85 nationalities. Imec is headquartered in Leuven, Belgium and also has distributed R&D groups at a number of Flemish universities, in the Netherlands, Taiwan, USA, China, and offices in India and Japan. In 2017, imec’s revenue (P&L) totaled 546 million euro. Further information on imec can be found at www.imec-int.com.
1 This will strictly be technology related, with no company promotions. The talks are expected to be visionary, forward looking with links to applications. They will explain what is the technological development; how is it unique; how can this be realized.
Clinical Research Malaysia is delighted to announce the appointment of Joanne Yeoh as the Head of Clinical Operations as of 1st June 2018.
Prior to Clinical Research Malaysia, Joanne managed clinical operations across Malaysia, Singapore, Taiwan and Hong Kong for Covance Clinical Development Services, Malaysia. Apart from Clinical Operations, Joanne supported other additional roles on top of her primary duties that included eDC super user for RAVE, AP representative for process improvement of protocol deviation and clinical operations representative for start-up improvement process initiative for AP. Joanne climbed up the ladder to be Clinical Operations Manager/Country Lead from 2014 until 2017. Read more
CLINICAL RESEARCH MALAYSIA
Suite E-10-20, Amcorp Business Suites,
Menara Melawangi, Amcorp Trade Centre,
No. 18, Jalan Persiaran Barat,
46050 Petaling Jaya,
Selangor Darul Ehsan, Malaysia.
In The News
19 October |9:00 am - 23 October |4:30 pm UTC+1